Skip to main content

Our Research

Every year, more than 17,000 children in the United States and 400,000 worldwide are diagnosed with cancer. While research has brought the overall survival rate above 80%, cancer remains the leading cause of death by disease for children. Treatments for many pediatric cancers are decades old, and even when a child does survive, they are often forced to deal with debilitating side effects long after they are cancer-free.

At CURE, our mission is to conquer childhood cancer by funding targeted research that will save lives and give survivors their best quality of life. Our research priorities are two-fold. First, we prioritize research that will lead to more effective treatments for children within two to three years. We also prioritize research aimed at solving recurrent and hard-to-treat cancers for which no effective treatment exists.

Over the past twelve years, we have invested more than $43 million in innovative research, resulting in important discoveries and treatment options. We are a leader in advancing precision medicine for children, investing $12 million in precision medicine initiatives over the last six years. Additionally, CURE invests more than $5 million annually in specific research efforts at top pediatric institutions nationwide.

Precision Medicine
Current Research
Fellows
For Researchers